Buy Budesonide Powder Inhalation Antiasthmatic 51333-22-3 , Budesonide Powder Inhalation Antiasthmatic 51333-22-3 Suppliers, Manufacturers, Traders









Budesonide Powder Inhalation Antiasthmatic 51333-22-3 Suppliers

budesonide powder inhalation antiasthmatic 51333-22-3

Welcome to inquiry!

Email: tony@kafenbio.com

WhatsApp: +8618002259573

Skype: tony_14616

www.pharmhormone.com

 
Budesonide Powder Inhalation Antiasthmatic 51333-22-3
 
Budesonide Basic Info.:
 
Product Name: Budesonide
Synonyms: Dexbudesonide;TriaMcinolone-D5;Preferid;Pulmicort;Spirocort;S-1320;Rhinocort;Bidien;Cortivent.
CAS: 51333-22-3
MF: C25H34O6
MW: 430.5339
EINECS: 257-139-7
Assay: 99.5%
Density: 1.27g / cm3
Boiling point: 599.7 °C at 760 mmHg
Flash Point: 201.8 °C
Melting point: 221-232°C (dec.)
Storage temp.: Store at RT, Ventilated, low-temperature ,dry storeroom.
Appearance: White Solid
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Steroids
Usage: 
(1)A non-halogenated glucocorticoid related to triamcinolone hexacetonide. Used as an antiinflammatory agent
(2)laxative, antineoplastic
(3)The oral capsule is used for the treatment of mild to moderate active Crohn's disease. The oral tablet is used for induction of remission in patients with active, mild to moderate ulcerative colitis. The oral inhalation formulation is used for the treatme.
 
Budesonide Attribute:
 
Budesonide is a glucocorticoid steroid for the treatment of asthma, COPD and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. In addition, it is used for inflammatory bowel disease. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
 
Budesonide Effect:
 
Budesonide is nebulized for maintenance and prophylactic treatment of asthma. also for treatment and prevention of nasal polyposis. maintenance of remission (for up to 3 months) of Crohn's disease (mild-to-moderate) involving the ileum and/or ascending colon. Budesonide assists in the induction of remission in patients with active ulcerative colitis.
 
CAS Number:51333-22-3

Guangzhou Kafen Biotech Co.,Ltd.

No.128,Hanxing East Rd, Zhongcun, Panyu District, Guangzhou, Guangdong, China, guangzhou, china

china china

Budesonide Budesonide
budesonide powder inhalation antiasthmatic 51333-22-3

Welcome to inquiry!

Email: tony@kafenbio.com

WhatsApp: +8618002259573

Skype: tony_14616

www.pharmhormone.com

 
Budesonide Powder Inhalation Antiasthmatic 51333-22-3
 
Budesonide Basic Info.:
 
Product Name: Budesonide
Synonyms: Dexbudesonide;TriaMcinolone-D5;Preferid;Pulmicort;Spirocort;S-1320;Rhinocort;Bidien;Cortivent.
CAS: 51333-22-3
MF: C25H34O6
MW: 430.5339
EINECS: 257-139-7
Assay: 99.5%
Density: 1.27g / cm3
Boiling point: 599.7 °C at 760 mmHg
Flash Point: 201.8 °C
Melting point: 221-232°C (dec.)
Storage temp.: Store at RT, Ventilated, low-temperature ,dry storeroom.
Appearance: White Solid
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Steroids
Usage: 
(1)A non-halogenated glucocorticoid related to triamcinolone hexacetonide. Used as an antiinflammatory agent
(2)laxative, antineoplastic
(3)The oral capsule is used for the treatment of mild to moderate active Crohn's disease. The oral tablet is used for induction of remission in patients with active, mild to moderate ulcerative colitis. The oral inhalation formulation is used for the treatme.
 
Budesonide Attribute:
 
Budesonide is a glucocorticoid steroid for the treatment of asthma, COPD and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. In addition, it is used for inflammatory bowel disease. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
 
Budesonide Effect:
 
Budesonide is nebulized for maintenance and prophylactic treatment of asthma. also for treatment and prevention of nasal polyposis. maintenance of remission (for up to 3 months) of Crohn's disease (mild-to-moderate) involving the ileum and/or ascending colon. Budesonide assists in the induction of remission in patients with active ulcerative colitis.
 
CAS Number:51333-22-3